Literature DB >> 11738912

Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin.

M C García-Sáenz1, A Arias-Puente, M J Fresnadillo-Martinez, C Carrasco-Font.   

Abstract

PURPOSE: To evaluate the penetration of ciprofloxacin, levofloxacin, and moxifloxacin into the aqueous humor after oral administration.
SETTING: Alcorcon Hospital, Madrid, Spain.
METHODS: Forty-two patients having cataract surgery were randomly divided into 3 groups the day before surgery. The first group received 2 oral 500 mg doses of ciprofloxacin at 12-hour intervals. The second group received a single oral 500 mg dose of levofloxacin. The third group received a single oral 400 mg dose of moxifloxacin. At the time of surgery, 0.1 mL aqueous fluid was aspirated from the anterior chamber just before the operation and immediately stored at -80 degrees C. Drug concentrations were measured using a biological assay.
RESULTS: The mean aqueous level of ciprofloxacin was 0.50 microg/mL +/- 0.25 (SD); of levofloxacin, 1.50 +/- 0.50 microg/mL; and of moxifloxacin, 2.33 +/- 0.85 microg/mL. The mean aqueous levels of levofloxacin and moxifloxacin were above the 90% minimum inhibitory concentration for most of the common microorganisms that cause endophthalmitis.
CONCLUSIONS: Therapeutic concentrations of fluoroquinolones, mainly levofloxacin and moxifloxacin, were reached with oral administration. These antibiotics may be effective for prophylaxis and adjuvant therapy of bacterial endophthalmitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738912     DOI: 10.1016/s0886-3350(01)00997-x

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  12 in total

1.  Penetration of moxifloxacin into the human aqueous humour after oral administration.

Authors:  G Kampougeris; A Antoniadou; E Kavouklis; Z Chryssouli; H Giamarellou
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

2.  Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors.

Authors:  Stéphane Bronner; François Jehl; Jean-Daniel Peter; Marie-Cécile Ploy; Corinne Renault; Pierre Arvis; Henri Monteil; Gilles Prevost
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

3.  Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery.

Authors:  Federico Pea; Ettore Ferrari; Federica Pavan; Derri Roman-Pognuz; Francesco Bandello; Mario Furlanut
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

4.  [The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva].

Authors:  M J Koss; M Eder; M S Blumenkranz; V Klauss; C N Ta; H M de Kaspar
Journal:  Ophthalmologe       Date:  2007-01       Impact factor: 1.059

5.  Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.

Authors:  Seenu M Hariprasad; William E Mieler; Gaurav K Shah; Kevin J Blinder; Rajendra S Apte; Nancy M Holekamp; Matthew A Thomas; Jingduan Chi; Randall A Prince
Journal:  Trans Am Ophthalmol Soc       Date:  2004

6.  Stenotrophomonas maltophilia induced post-cataract-surgery endophthalmitis: Outbreak investigation and clinical courses of 26 patients.

Authors:  S Horster; L Bader; U Seybold; I Eschler; K G Riedel; J R Bogner
Journal:  Infection       Date:  2008-12-05       Impact factor: 3.553

7.  Vitreous penetration of orally administered gatifloxacin in humans.

Authors:  Seenu M Hariprasad; William F Mieler; Eric R Holz
Journal:  Trans Am Ophthalmol Soc       Date:  2002

Review 8.  Gender analysis of moxifloxacin clinical trials.

Authors:  Elisa Chilet-Rosell; Ma Teresa Ruiz-Cantero; Ma Angeles Pardo
Journal:  J Womens Health (Larchmt)       Date:  2013-11-01       Impact factor: 2.681

9.  Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections.

Authors:  Darlene Miller
Journal:  Clin Ophthalmol       Date:  2008-03

Review 10.  Pharmacokinetics of intravitreal antibiotics in endophthalmitis.

Authors:  Medikonda Radhika; Kopal Mithal; Abhishek Bawdekar; Vivek Dave; Animesh Jindal; Nidhi Relhan; Thomas Albini; Avinash Pathengay; Harry W Flynn
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.